Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for preoperative intraocular pressure reduction in hypertensive glaucoma
IRCT20230524058280N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexmedetomidine in Glaucoma and ocular hypertension (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: intraocular pressure. Started Jun 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on IRCT20230524058280N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230524058280N1.